Covid drives a record jump in research spending for big pharma

The world’s largest developers spend huge amounts on research and development each year, and the outbreak of Covid has added substantial sums to those endeavours. The 11 big pharma firms saw their combined R&D investments jump 11% in 2021 on the previous year, the biggest annual rise in at least five years.